XML 41 R27.htm IDEA: XBRL DOCUMENT v3.19.2

Organization and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Jun. 30, 2019

Reconciliation of Deferred Revenue Balances

A reconciliation of the beginning and ending balances of deferred revenue is shown in the table below:

		Years Ended June 30,
		2019				2018
Deferred revenue - beginning balance		$	2.6			$	2.6
Revenue recognized			(7.9	)			(14.0	)
Prepayments			7.5				14.0
Deferred revenue - ending balance		$	2.2			$	2.6

Schedule of Company's Revenue by Type

The following table represents the Company’s revenue by type for the years ended June 30, 2019, 2018 and 2017 (in thousands):

		Years Ended June 30,
(In millions)		2019				2018 (a)				2017 (a)
Molecular diagnostic revenues:
Hereditary Cancer Testing		$	479.7			$	471.4			$	525.5
GeneSight			112.6				124.9				78.4
Prenatal			104.9				—				—
Vectra			48.3				55.2				45.2
Prolaris			25.5				21.5				11.1
EndoPredict			10.4				8.8				7.7
Other			8.0				8.6				11.5
Total molecular diagnostic revenue			789.4				690.4				679.4
Pharmaceutical and clinical service revenue			61.7				53.3				49.3
Total revenue		$	851.1			$	743.7			$	728.7

(a) Amounts adjusted due to the adoption of Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606)

Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations

The following is a reconciliation of the denominators of the basic and diluted earnings per share computations:

		Years Ended June 30,
		2019				2018				2017
Denominator:
Weighted-average shares outstanding used to    compute basic EPS			73.5				69.4				68.3
Effect of dilutive stock options			2.5				2.6				0.5
Weighted-average shares outstanding and dilutive    securities used to compute diluted EPS			76.0				72.0				68.8

Schedule of Anti-Dilutive Options and Restricted Stock Units Excluded from EPS Computation

These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:

		Years Ended June 30,
		2019				2018				2017
Anti-dilutive options and RSUs excluded from EPS    computation			0.8				—				7.0

ASC 606

Schedule of Recast of Certain Prior Period Amounts to Conform with the Adoption of Topic 606

The Company recast certain prior period amounts to conform with the adoption of Topic 606, as shown in the table below (in thousands):

		FY2018												FY2017
		As Reported				Adjusted for ASC 606				As Adjusted				As Reported				Adjusted for ASC 606				As Adjusted
Total revenue		$	772.6			$	(28.9	)		$	743.7			$	769.9			$	(41.2	)		$	728.7
Selling, general, and administrative expense			467.1			$	(32.1	)			435.0				476.4			$	(36.5	)			439.9
Income tax provision			(14.0	)		$	1.0				(13.0	)			20.6			$	(1.6	)			19.0
Net income attributable to Myriad Genetics,    Inc. stockholders			131.1			$	2.2				133.3				20.5			$	(3.1	)			17.4
Earnings per share:
Basic		$	1.89			$	0.03			$	1.92			$	0.30			$	(0.05	)		$	0.25
Diluted		$	1.82			$	0.03			$	1.85			$	0.30			$	(0.05	)		$	0.25

		FY2018												FY2017
		As Reported				Adjusted for ASC 606				As Adjusted				As Reported				Adjusted for ASC 606				As Adjusted
Trade accounts receivable		$	98.3			$	1.2			$	99.5			$	90.2			$	(1.0	)		$	89.2
Retained earnings			52.9				1.2				54.1				(78.2	)			(1.0	)			(79.2	)

Accumulated Foreign Currency Adjustment Attributable to Parent [Member]

Schedule of Cumulative Translation Adjustments Included in Accumulated Other Comprehensive Income/(Loss)

The following table shows the cumulative translation adjustments included in accumulated other comprehensive income/(loss):

Ending balance June 30, 2018		$	(4.1	)
Period translation adjustments			(3.1	)
Ending balance June 30, 2019			(7.2	)

X

- Definition

Tabular disclosure of contract balances and changes in contract balances.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130551-203045

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the components of accumulated other comprehensive income (loss).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669686-108580

+ Details

Name:	us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=109236672&loc=d3e765-108305

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.10-01.(b)(6))
-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22580-107794

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=109236672&loc=d3e725-108305

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

+ Details

Name:	us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: